Directorate General of Drug Administration (DGDA)

Phase I trial of Bangavax approved

The government today (July 17, 2022) approved phase I clinical trial of Bangavax, a homegrown coronavirus vaccine developed by Globe Biotech.

67% medicine retailers can't identify antibiotics: DGDA

Around 67 percent of medicine retailers do not have knowledge of antimicrobial drugs and they cannot identify the antibiotics, finds a study by the Directorate General of Drug Administration (DGDA).

Deaths of 2 children: DGDA orders collection of Napa syrup samples for lab test

The Directorate General of Drug Administration (DGDA) has directed all of its divisional and district officials to collect samples of a Napa syrup -- belonging to a certain batch number -- produced by Beximco Pharmaceuticals Limited last December from the market and send those for lab test.

Eskayef, Beximco get DGDA's marketing authorisation for Covid-19 pill molnupiravir

The Directorate General of Drug Administration (DGDA) has issued marketing authorisation for the first-ever Covid-19 pill molnupiravir to two pharmaceutical companies in the country.

Supply of ranitidine suspended for cancer-causing ingredients

The Directorate General of Drug Administration (DGDA) has suspended production, distribution, sale and export of heartburn drug ranitidine following detection of cancer-causing ingredients in its raw materials.

Remove expired drugs by July 2

Health and Family Welfare Minister Zahid Malik yesterday announced that all expired medicines must be removed from pharmacies across the country by July 2.

Seize, destroy all expired drugs

Expressing grave concern at the storing and sale of expired medicines, the High Court yesterday directed the government to confiscate all expired medicines from pharmacies across the country and destroy those within a month.

July 17, 2022
July 17, 2022

Phase I trial of Bangavax approved

The government today (July 17, 2022) approved phase I clinical trial of Bangavax, a homegrown coronavirus vaccine developed by Globe Biotech.

May 18, 2022
May 18, 2022

67% medicine retailers can't identify antibiotics: DGDA

Around 67 percent of medicine retailers do not have knowledge of antimicrobial drugs and they cannot identify the antibiotics, finds a study by the Directorate General of Drug Administration (DGDA).

March 13, 2022
March 13, 2022

Deaths of 2 children: DGDA orders collection of Napa syrup samples for lab test

The Directorate General of Drug Administration (DGDA) has directed all of its divisional and district officials to collect samples of a Napa syrup -- belonging to a certain batch number -- produced by Beximco Pharmaceuticals Limited last December from the market and send those for lab test.

November 9, 2021
November 9, 2021

Eskayef, Beximco get DGDA's marketing authorisation for Covid-19 pill molnupiravir

The Directorate General of Drug Administration (DGDA) has issued marketing authorisation for the first-ever Covid-19 pill molnupiravir to two pharmaceutical companies in the country.

November 14, 2019
November 14, 2019

Supply of ranitidine suspended for cancer-causing ingredients

The Directorate General of Drug Administration (DGDA) has suspended production, distribution, sale and export of heartburn drug ranitidine following detection of cancer-causing ingredients in its raw materials.

June 25, 2019
June 25, 2019

Remove expired drugs by July 2

Health and Family Welfare Minister Zahid Malik yesterday announced that all expired medicines must be removed from pharmacies across the country by July 2.

June 19, 2019
June 19, 2019

Seize, destroy all expired drugs

Expressing grave concern at the storing and sale of expired medicines, the High Court yesterday directed the government to confiscate all expired medicines from pharmacies across the country and destroy those within a month.

push notification